abstract |
The present application is directed to a pharmaceutical composition comprising ( R )- N -(4-chlorophenyl)-2-((1 S , 4 S )-4-(6-fluoroquinolin-4-yl) cyclohexyl) propanamide methane sulfonic acid salt that is resistant to salt disproportionation: (I) |